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Chromosome conformationa b s t r a c t
The information encoded in genomes supports the differentiation and function of the more than
200 unique cell types, which exist in various mammalian species. The major mechanism driving
cellular differentiation and speciﬁcation is differential gene expression regulation. Cis-acting
enhancers and silencers appear to have key roles in regulating the expression of mammalian genes.
However, these cis-acting elements are often located very far away from the regulated gene.
Therefore, it is hard to ﬁnd all of them and link them to the regulated gene. An intriguing and unre-
solved issue of the ﬁeld is to identify all of the enhancers of a particular gene and link these short
regulatory sequences to the genes they regulate and thus, reliably identify gene regulatory enhancer
networks. Recent advances in molecular biological methods coupled with Next-Generation
Sequencing (NGS) technologies have opened up new possibilities in this area of genomics. In this
review we summarize the technological advances, bioinformatics challenges and the potential
molecular mechanisms allowing the construction of enhancer networks operating in speciﬁc cell
types and/or activated by various signals.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Why mammalian gene regulation is so hard to study?
Gene expression is the result of a very complex process
achieved by the coordinated action of multiple layers of regulators.
In prokaryotes, genes are organized into operons, and using a sin-
gle promoter, the entire stretch of DNA is transcribed into RNA
(Fig. 1A). These so-called ‘‘polycistronic’’ RNAs often encode func-
tionally related members of an enzyme cascade regulating a partic-
ular metabolic process. Thus, in most of the cases prokaryotes
utilize one promoter-proximal, restricted cis-element to initiate
transcription. However, eukaryotic organisms have evolved to uti-
lize much more complex mechanisms to regulate gene expression.
In fact, one of the driving forces of eukaryotic evolution is believed
to be the introduction of elaborate gene regulatory circuits. This is,
in part, manifested in the concept of C value enigma, which is the
observation that genome size does not correlate with organismal
complexity [1]. The number of protein coding genes also does
not show correlation with complexity.Unlike prokaryotic genes, eukaryotic genes are ‘‘monocistronic’’
and their regulation is usually much more complex. The fact that
genes can have multiple promoters with unique promoter ele-
ments makes the picture even more crowded and complicated. In
addition, probably most if not all eukaryotic genes possess inter-
genic, as well as intragenic cis-regulatory elements (enhancers/
silencers) to ﬁne-tune their expression in a cell type and/or biolog-
ical context dependent manner (Figs. 1B and 2B). To clearly under-
stand the detailed molecular mechanisms controlling gene
expression, one needs to identify the factors responsible for gene
regulation and their precise action on one or multiple well-deﬁned
cis-regulatory element(s). Before the genomic era, investigations
were limited methodologically and gene regulation was studied
with methods restricted to the analysis of the expression of a
few genes and/or biased/restricted to the immediate vicinity of a
given gene. The classical way of studying gene expression used
a set of so-called ‘‘promoter bashing approaches’’ evaluating the
genomic regions in the close proximity of the transcription start
site (TSS) to identify the core sequence driving the expression of
the given gene [2]. These approaches were based on transient
transfections and deletion and insertion mutagenesis, which are
still used. The discovery of enhancers predicted the complex
regulation of a gene, because these cis-regulatory elements can
Fig. 1. Transcription regulation in prokaryotes and eukaryotes and the complexity of gene regulation in eukaryotic cells. (A) Prokaryotic gene expression is based on operons
in which a gene cluster is under the control of two genomic (promoter) regions. The ﬁrst promoter located at the 50 end is responsible for the expression of the regulator
protein, which in turn silences the whole operon via binding to the operator region. In the presence of an activating stimulus the regulator cannot bind to the operator region,
thus the second promoter will be active and leads to the efﬁcient expression of the enzyme coding genes producing polycistronic RNA molecules encoding more protein
products. (B) Eukaryotic genes are typically regulated by cis-acting elements located in the non-coding part of the genome. These elements can be located far away from their
target genes, might be even in another chromosome, thus it is challenging to pair them with their genes. RNA synthesized from a eukaryotic gene is monocistromic and
undergoes the process called splicing, in which the intronic regions are excluded from the nascent transcript before translation. (C) Eukaryotic transcription might be
coordinately regulated in the so-called transcription factories. These subnuclear compartments might be, in part, stabilized by the CTCF/cohesin protein complexes and
permit the expression of genes in a well-coordinated manner, mechanically connecting genes regulated by the same signal, but residing on distinct chromosomes. A
hypothetical scenario is depicted in which several genomic regions on distinct chromosomes are linked by CTCF/cohesin interactions and co-localize in the nucleus forming a
transcription factory. Interchromosomal interactions are marked by asterisks.
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downstream 30 of the regulated gene [3]. The inherent pitfalls of
the ﬁrst studies were recognized soon, but without the technical
advances no one could easily go beyond the technical limitations
to dissect the regulation of gene networks, not even just a particu-
lar gene. Therefore, most studies identiﬁed promoter proximal ele-
ments usually restricted to 10–20 kb upstream of the designatedpromoter. Using these typical ‘‘promoter bashing’’ technologies
researchers were not able to consider and/or evaluate the contribu-
tion of multiple and/or far way enhancers or intra- or interchromo-
somal interactions. This represented bias and created a roadblock
in understanding complex gene regulation.
An additional important aspect of gene expression regulation
research is that one would need methods to assess the expression
Fig. 2. Schematic representation of enhancer function and the establishment of cell type speciﬁc gene expression program. (A) Enhancer-gene pairs are located within a
topological domain bordered by CTCF/cohesin protein complexes. Enhancers may be located long distances away relative to the TSS of the regulated gene. Upon signal-
speciﬁc enhancer activation transcription factor binding and chromatin remodeling occurs leading to the deposition of enhancer marks for instance H3K27ac by the
coactivator complex. Enhancers activated by the stimuli then get into the close proximity of the promoter region potentially by an eRNA-dependent mechanism, which also
relies on the cohesin complex. After these steps the enhancers can initiate or boost the expression of the target by supporting the assembly of the general transcription factors
and the mediator complex along with the deposition of the active TSS mark H3K4me3. (B) Cell type speciﬁc gene expression program is established by the existence of various
cell type speciﬁc transcription factors (pioneering/bookmarking factors), which can shape the functional cis-acting element landscape of the genome. Though the higher order
chromatin structure is also implicated in the designation of active gene domains. In cell A, the functional gene domain is demarked by CTCF/cohesin co-bound regions and the
active enhancer element is occupied by the pioneering/bookmarking or the lineage determining factor, thus support an entry point to the signal dependent transcription
factor. In cell B, the same gene domain is active, but because of the presence of a different pioneering/bookmarking factor it uses a different regulatory element, which in turn
lead to a differential gene expression output, while in cell C the chromatin conformation of the locus is reshaped due to the differential binding of CTCF/cohesin, hence a new
enhancer unit can get into the proximity of Gene A possessing another cell type speciﬁc pioneering/bookmarking factor with the ability to push the element into a poised for
activation state.
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the impact of a particular signal, on what is now called global gene
expression.
The ﬁrst attempt to provide information regarding global gene
expression was reported in 1982, when the ﬁrst gene array was
constructed to assay 378 transcripts in normal and tumor tissues
[4]. Until 1995 several studies were published using this ﬁlter
paper spotted technology to document the gene expression pattern
of cancerous versus normal cells, and also the anti-proliferative
action of interferons [5,6]. The usage of miniaturized microarray
technology was ﬁrst applied to measure the differential expression
of 45 Arabidopsis genes [7]. These initial efforts launched the now-
adays’ well-known microarray technology, which transformed the
ﬁeld of transcription regulation.2. New NGS-driven enabling technologies have emerged
As the result of the genome programs and the technological rev-
olution coming with it, major breakthroughs helped scientists
working in the ﬁeld of mammalian gene expression regulation.
As a key example, the proﬁling of transcription factor binding
sites (TFBSs) and histone modiﬁcation patterns along with nucleo-
some positions have been determined by linking Chromatin Immu-
noprecipitation (ChIP) to microarray technology, for review see [8].
This allowed the identiﬁcation of histone modiﬁcation and/or
TFBSs in a quasi genome-wide fashion and showed how old molec-
ular biology techniques (i.e. immunoprecipitation) can be effec-
tively coupled to genome-based approaches (i.e. microarrays of
genomic DNA fragments). During the last several years, sequencing
Table 1
RNA-based high throughput methods to study gene expression.
Method Applicability Advantage Disadvantage
Microarray Method to detect gene expression changes at the level of mRNA.
Chip based approach which is based on the detection of
hybridization between the oligonucleotides present on the solid
surface and the cDNA molecules reverse transcribed from the
sample.
It has been coupled to many molecular biology methods including:
ChIP, 4C, DNase I assay.
 Allows the detection of a
wide range of targets
simultaneously.




 Cannot give genome-wide information.
 Limited dynamic range.
 Poor resolution if combined with ChIP or
other methods mapping nucleosome posi-
tions or interaction frequency.
RNA-Seq Method to measure the overall amount of steady-state RNA
present in the cells. Two major RNA-Seq methods are widely used
in the ﬁeld: total RNA-Seq measuring all the RNA pieces and Poly-A
RNA-Seq measuring those RNA molecules possessing Poly-A tail.
RNA-Seq can be used to measure the amount and location of RNA
molecules by separating the subcellular fractions. Separation of
chromatin-associated, nucleoplasmic, and cytoplasmic fractions of
RNA transcripts can carry information about the localization of
various transcripts.
 Highly efﬁcient genome-
wide measurement of total
(steady-state) RNA level.
 Precise detection of tran-
scription to a single base
resolution.
 Good signal to noise ratio.
 Highly reproducible.
 Useful to gain information
about splicing, exon inclu-
sion, axon occlusion.
 Can be used to annotate
unknown transcripts.
 It has a large dynamic range
for detecting gene
expression.
 Depending on the fragmentation method
during library preparation might bias the
mappable reads toward gene bodies.
 Generation of strand speciﬁc libraries can be
challenging and laborious and prone to form
artifacts.
GRO-Seq Highly efﬁcient method to determine the freshly synthesized
nascent RNA in a genome-wide manner. Directly measures the
frequency of transcription initiation and transcriptional rate. A
modiﬁed version of GRO-Seq can measure transcription frequency
by measuring 50 capped nascent RNA.
 Highly speciﬁc nascent RNA
detection.





 Largely independent of RNA
stability.
 Does not depend on avail-
ability of an antibody or
conditions of cross-linking.
 Very labor intensive and the optimization
can be very laborious.
 Highly dependent on efﬁcient nuclei
isolation.
 There is no standardized library preparation
kit.
 Library preparation is very sophisticated and
requires reasonable experience.
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array-based methods. With the ability to sequence tens of millions
of short DNA sequences in a parallel fashion, more applications,
which could be only imagined before, became a reality. This rapid
evolution of sequencing, now termed Next-Generation Sequencing
(NGS), entirely transformed the ﬁeld of gene expression research,
along with other areas of research. The combination of NGS with
simple molecular biology approaches proved to be very effective
and led to the rapid generation of genome-wide data in a number
of areas including whole genome sequencing, mRNA sequencing
and revealing MNase and DNase I hypersensitive sites, as reviewed
in [8] (Table 1). For high throughput TSS sequencing, similar meth-
ods were developed simultaneously for different sequencing plat-
forms based on the CAGE (Cap Analysis of Gene Expression), 50
SAGE (Serial Analysis of Gene Expression) and 50 RACE (Rapid
Ampliﬁcation of cDNA Ends) methods [9]. ChIP has been one of
the earliest applications linked to NGS and led to the determina-
tion of histone modiﬁcation patterns, co-factor and transcription
factor binding sites throughout the genome [8]. These results sup-
plied the ﬁrst set of evidence that cis-acting elements are likely to
be widespread in the mammalian genomes and are mostly located
in intergenic regions, also at large distances from the TSSs of the
putative targeted gene.
Our ability to detect intra- and interchromosomal interactions
has also changed quite a bit. The development of technologies,
such as 3C, greatly increased one’s options to reveal the interaction
map of cis-elements beyond their interactions with the regulated
genes [10]. The 3C method is based on the ﬁxation of chromatin
loops mediated by protein complexes bound to DNA. After stabiliz-
ing the interactions, a restriction enzyme is used to cut the genome
into smaller pieces containing the compatible sticky ends. Then thechromatin is subjected to ligation in a highly diluted fashion. This
reaction favors intramolecular ligation events, thus capable of con-
necting those genomic regions residing in the proximity of each
other.
Over the last decade 3C has been linked to NGS and also com-
bined with ChIP resulted in the following technologies (3C-Seq,
4C-Seq, 5C, ChIA-PET, Hi-C) (Table 2). Depending on the biological
question, one can choose these methods to reveal the physical con-
formation of the genome or a particular locus. The 4C assay can be
very useful if a singular genomic element and its interactions are
examined. Initially, libraries obtained from 4C experiments were
hybridized to microarrays to get insights into chromatin interac-
tions [11]. 3C-sequencing basically holds the same advantage as
the 4C experiments and it can be used for detecting one to all inter-
actions [12]. 5C overcomes the disadvantage of 4C and 3C-
sequencing by offering the opportunity to map all the interactions
in a large chromosomal territory [13]. 4C [14] and 5C [15] have
been linked to NGS, now providing genome-wide information.
However, Hi-C (Table 2) has been the most powerful amongst
these by having the ability to map all the interactions genome-
wide, in an unbiased way [16]. ChIA-PET [17] is the genome-wide
version of the method called ChIP-loop [18], in which the combina-
tion of ChIP and 3C is utilized to map the interactions between any
two loci bound by the investigated protein (Table 2).
These technological developments apparently produced the
possibility to reveal interaction maps about the identiﬁed cis-act-
ing elements and their promoters. In addition, these can inform
one about the organization of higher-order chromatin structure
in the nucleus. These technologies are quite robust, provide a lot
of data, are prone to artifacts and require signiﬁcant bioinformatics
efforts to analyze and interpret the data.
Table 2
NGS coupled methods to study transcription factor binding sites, epigenetic marks and chromatin structure.
Method Applicability Advantage Disadvantage
ChIP-Seq Powerful method to detect DNA–protein
interactions. It can be used for detecting
transcription factor binding sites, co-
regulators, histone modiﬁcations and positions
of histones.
 Good signal to noise ratio compared to ChIP-
chip.
 Genome-wide detection of binding sites for
a chromatin bound protein.
 High resolution detection of the binding
sites can be achieved by using ChIP-exo,
when the usage of an exonuclease helps to
detect the exact DNA binding motif based
on nuclease protection.
 The result is depending on the avail-
ability of a highly efﬁcient antibody.
 Crosslinking and sonication must be
carefully optimized to get meaningful
data.
DNase-Seq Using non-speciﬁc endonucleases this method
is able to map NFRs (open chromatin) genome-
wide. Preferentially cleaves NFRs, thus it
provides an inverse approach to MNase-Seq.
FAIRE-Seq can be also used to map open
chromatin.
 Does not rely on antibodies.
 Can be easily adapted to various cell lines.
 Not speciﬁc, maps all the NFRs.
 Other datasets (ChIP-Seq) are required
to identify the factors within NFRs.
 ChIP-Seq is required to identify the
trans-factors sitting in the open chro-
matin regions.
MNase-Seq Method to study nucleosome position,
occupancy, composition and modiﬁcation
genome-wide.
 Cost-effective.
 Does not depend on antibody.
 Might generate too small pieces of DNA
for which a specialized library prepara-
tion is needed.
 Other datasets (ChIP-Seq) are required
to identify the factors bound to NFRs,
because it supports information only
about nucleosomes and their location.
FAIRE-Seq Method to detect NFRs based on chromatin
crosslinking.
 Cost effective.
 Does not rely on antibody.
 Low technical variability.
 Does not require enzymes.
 Not effective for nucleosome depleted
promoter detection.
 Lower signal to noise ratio and resolu-
tion compared to DNase-Seq.
 Fixation variation can affect sample to
sample difference.
3C-Seq, 4C-Seq These methods are based on the conventional
3C method in which cross-linked chromatin
loops mediated by protein-DNA or protein–
protein interactions are assayed by NGS
technology.
 Allows large scale mapping of chromatin
interactions.
 Offers very good resolution compared to
similar technologies.
 Cost-effective.
 Restricted to the analysis of one geno-
mic point.
 Optimization can be challenging
between cell types.
5C 3C-based method to detect genomic
interactions in a mega-base scale range.
 Allows large scale mapping of chromatin
interactions.
 It allows the concurrent detection of interac-
tions between multiple sequences.
 Allows the prediction of the 3D organization
of the given locus.
 Primer design is very challenging.
 Interaction detection is limited to a
restricted genomic locus.
 Worst resolution between high
throughput loop detection methods.
Hi-C The method is based on 3C. It allows the
genome-wide detection of all loops present in a
given cell type.
 Allows the detection of all the chromatin
loops in an unbiased way.
 Allows the prediction of the 3D organization
of the genome.
 High sequencing depth is required for
higher resolution.
 Analysis can be challenging, when the
ﬁnal aim is the detection of nuclear
compartmentalization.
ChIA-PET This method is the combination of 3C and ChIP
coupled to NGS, which allows the genome-
wide detection of all loops present associated
with a given protein.
 Allows the detection of all chromatin inter-
actions related to a given protein.
 Generate the cistrome and reveal the chro-
matin interactions between binding sites.
 Highly efﬁcient antibody is required.
 Library preparation is sophisticated and
laborious.
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The necessity of bioinformatics became apparent with the
delivery of sequencing data to the molecular biology laboratory.
Post-genomic bioinformatics has been evolving in concert with
the emergence of NGS methods, but such evolution is not without
difﬁculties and dead ends, especially considering the fact that two
different ﬁelds, molecular biology and informatics, needed to
merge. It is safe to say that as of today there are still no standard-
ized algorithms, or even consensus quality control metrics to
qualify and interpret NGS data. The fact that the data sets need
to be deposited in central repositories is a necessary step and
allows re-analyses by independent groups and/or independent
methods. The largest such source is the NCBI Sequence Read
Archive, which contains the raw sequence reads of several tens
of thousands of NGS samples. These sequences can be freely
downloaded, reanalyzed and mapped to the appropriate reference
genome. Alignment of spliced reads for RNA-Seq was a unique
challenge, which had been overcome e.g. with the TopHat soft-ware [19] and ﬁnally led to a now widely used RNA-Seq analysis
pipeline.
Determination of cistromic and epigenomic enrichments are
accomplished with several distinct algorithms specialized for
shorter or broader regions with different, e.g. peak-like, column-
like, extended or valley-like shapes. Differences in read distribu-
tions of a sample lead to slightly, or sometimes not so slightly, dif-
ferent results, in terms of the number of the predicted binding site
overlaps between occupied genomic regions, etc. There is also no
real consensus in the way the results are plotted and presented
in publications. These can lead to confusions and disagreements
regarding the cistromes of transcription factors or the effects of
various signals.
Genomic ChIP-ed fragments of transcription factors ideally
show a Gaussian distribution near the TFBSs, forming peaks after
the alignment. The initial studies used SOAP, Bowtie and BWA,
but there are other sequence read mapper tools, as well for the
alignment. There are additional peak caller programs that have
been developed using different algorithms: CSAR searches for read
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work based on the local density of the reads with Poisson distribu-
tion. CisGenome uses negative binomial, and ZINBA uses zero-
inﬂated negative binomial distribution. There are more sophisti-
cated methods for peak calling, such as the BayesPeak, using the
Hidden Markov Model, see review about peak caller tools [20]. This
list of approaches testiﬁes that there is still a lack of consensus on
what to call a peak and how to count it.
It appears though that peak caller tools work relatively well
depending on the quality of the sample libraries and gives a quality
score, the edges and the summit of the peaks. Peak width is usually
a technical issue, but the summit has a biological relevance, as it is
very close to the putative TFBS(s). The ﬁrst widely used package,
which was able to search for motif enrichments and to map the
found matrices (back) to sequences thus designating the TFBSs,
was the MEME-MAST toolkit [21]. Based on the validated TFBSs,
more motif matrix databases were established: TRANSFAC [22],
MEME and JASPAR [23] have databases with their own similarity
weight matrix formats, which are used in several other databases.
Homer also developed a motif enrichment and TFBS searching sys-
tem, which includes others matrices as well as the ones with
Homer’s own format enriched from different ChIP-Seq samples
[24]. There is a special ChIP-Seq method called ChIP-exo, devel-
oped directly for the detection of TFBSs at a single nucleotide res-
olution. Fragments are shortened by an exonuclease from the 50 up
to the TFBS, thus resulting in a column-like shape after alignment
marking the exact place of the DNA binding [25]. Application of
this method may result in a much better resolution in determining
TFBSs.
Histone modiﬁcations usually cover broader regions of the gen-
ome, which calls for different kinds of algorithms. SICER [26] and
ZINBA were developed for this purpose, but certain peak callers
are also able to ﬁnd these kinds of regions by using different
parameters, such as MACS2 and Homer [20]. DNA binding of tran-
scription factors disrupts histone continuity establishing the so-
called nucleosome-free (or more precisely nucleosome-depleted)
regions (NFRs) with valley-like shapes in the histone (modiﬁca-
tion) landscapes. There are several methods allowing the detection
of nucleosome occupied and depleted regions. The ﬁrst one is
based on ChIP-chip [27,28], while others are based on MNase or
ChIP-Seq data [29]. Homer includes an NFR prediction function
for ChIP-Seq data, and we have also developed a method to ﬁnd
putative regulatory regions based on active histone mark land-
scapes [30]. Special NGS methods emerged in order to determine
the regulatory regions and as FAIRE– (Formaldehyde-Assisted Iso-
lation of Regulatory Elements) [31] and Sono-Seq [32] give peak-
like enrichments. Peak callers are also suitable in these cases to
determine these NFRs, as well. Sono-Seq is a simple method to ﬁnd
accessible chromatin regions using a size selection following the
sonication of the cross-linked chromatin. More recently, predictors
of broader regions (SICER, ZINBA) and NFRs are becoming suitable
for the processing of DNase I, MNase-Seq or other kinds of NGS
data.
4. How to link the regulator to the regulated?
The combined usage of molecular, NGS and bioinformatic meth-
ods and approaches continue to provide a large amount of useful
information about the location of cis-acting elements and the gene
expression proﬁle of a given cell type. However, aligning the regu-
latory elements to the affected genes remained very cumbersome,
if not impossible. The strategy to simply link TFBSs to the closest
regulated gene is not reliable in case of larger distances between
the proposed enhancers and the regulated genes. Experimental
evidence is required for such interactions, by methods such asChromosome Conformation Capture (3C) [10]. 3C, if done quantita-
tively, is suitable for measuring the interaction frequency between
any two loci in the genome. However, prior information (e.g. TFBSs
or histone modiﬁcation patterns) of the given loci is critical for the
experimental design. The development of Hi-C overcomes this
problem [16]. This method is based on 3C, of which ligation prod-
ucts are sequenced on an NGS platform documenting all genome-
wide interactions. However, its resolution is far from ideal to map
enhancer-promoter interactions. Fullwood et al. reported a new
technology called chromatin interaction analysis by paired-end
tag sequencing (ChIA-PET) in 2009 (Table 2). The method itself is
the combination of ChIP and 3C, which was ﬁrst applied to map
the chromatin interactions inﬂuenced by the estrogen receptor
alpha in the human genome [17]. The usage of this technology pro-
vided a tool to understand how a transcription factor can act from
long distances, and implied that chromatin interactions are one of
the driving molecular mechanisms for regulating gene expression
in the mammalian genomes.
Development of Global Run-On sequencing (GRO-Seq) was an
additional breakthrough. The procedure is based on the classical
nuclear run-on transcription assay, which has been used in molec-
ular biology for decades, providing a snapshot about the level of
in vivo (at least in an intact nucleus) synthesized nascent RNAs
[33]. If done as a time course, the dynamics of the induced/chang-
ing transcription can be assessed and even quantitated. GRO-Seq
was ﬁrst applied to primary human lung ﬁbroblasts in order to
map the amount, position and orientation of the transcriptionally
engaged RNA polymerases [34]. The obtained results were very
striking, showing that about 30% of the human genes are occupied
by active polymerases, genes are transcribed beyond the 30 end of
the annotated regions, and surprisingly, most promoters possess
engaged polymerases in the opposite orientation to the annotated
gene. This divergent transcription is associated with active genes,
but usually is not elongated efﬁciently to the upstream regions rel-
ative to the TSS [34].
The technical advance made it possible to go forward using
these approaches (Table 1) to reveal the complex regulation of
the genes in a genome-wide manner, however, the combination
of the approaches is necessary to understand and explain the most
exciting ﬁndings. In the following part of this review we make an
attempt to summarize the recent developments in the ﬁeld of data
integration based genomics regarding cistromic, transcriptomic
and chromatin structure related studies, which are based on
molecular biology of NGS coupled technologies.
5. Enhancers, the main drivers of gene expression
In complex genomes, cis-acting elements are dispersed and can
be located over several hundred kilobases away from their targeted
genes [35]. Developments regarding NGS rapidly expanded our
view about the putative location of regulatory elements and shed
light on the problematic nature of assigning enhancers to genes.
However, it has been shown in one of the earliest studies that their
proper action is indispensable and mutations occurring within the
core enhancer sequence may result in congenital disease [36].
Based on these data, the proper annotation of enhancers has
become an important and widely studied issue in the ﬁeld of tran-
scriptional regulation, and an absolute requirement for proper
annotation of genome function. Enhancers are DNA sequences with
the ability to recruit various types of transcription factors for the
interaction with the mediator complex, as well as with the mem-
bers of the (pre-)initiation complex. By looping mechanisms, the
complexes assembled on the DNA can facilitate RNA-polymerase
II (RNAPII) binding to the promoter, thus the initiation of gene
transcription [37]. It has been also shown that transcription factors
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remodeling enzyme complexes affecting the chromatin structure
to establish NFRs, thus facilitating transcription factor binding,
transcription initiation and elongation [38].
The appearance of MNase-, DNase I-, and ChIP-Seq (Table 2) as
main tools to interrogate open chromatin, transcription factor
binding and epigenetically marked histone landscapes has greatly
improved our understanding about the main features of enhancers.
Results from genome-wide studies mapping nucleosome occu-
pancy indicate that at cis-regulatory elements, histone replace-
ment is more enhanced than at other genomic locations not
harboring such enhancer-like properties [39]. Active promoters/
TSSs are hardly occupied by nucleosomes as well, thus these form
also NFRs. These results suggested that nucleosome stability con-
tributes to gene regulation [40]. Later, it has been shown that the
two alternative, minor histone variants, H3.3 and H2A.Z, are
enriched near NFRs [1].
High-resolution co-activator CREB-binding protein (CBP), p300
ChIP-Seq assessements provided further insights into the chroma-
tin signatures of enhancers. These proteins interact with various
transcription factors and possess histone acetyl-transferase activ-
ity, which makes them capable to modify histones [42]. Several
studies showed that these factors are good predictors of enhancer
function in a tissue speciﬁc manner, as reviewed in [43]. These
results suggest that CBP/p300 co-factors are key functional compo-
nents of the enhancer binding complexes.
Certain histone modiﬁcations also participate in cis-element
function and it has been shown that the main characteristic fea-
tures of active promoters are deﬁned by the residence of RNAPII
and TBP-associated factor 1 (TAF1), marked by NFRs ﬂanking with
trimethylated histone H3 at lysine 4 (H3K4me3), acetylated H3
(H3ac) and TFIID [44]. On the other hand, as previously mentioned
p300 is one of the most well-documented active enhancer marks
along with the enriched H3K4me1, H3K4me2 and H3K27ac, for a
review see [45]. These observations were conﬁrmed in different
cellular model systems leading to the identiﬁcation of enhancer
repertoires of a given cell type [46,47]. Based on these studies,
the identiﬁcation of enhancers and their characteristic features
are relatively straightforward, however, the annotation process to
the affected genes remained largely elusive.
Utilizing the features of RNA-Seq and GRO-Seq, another useful
feature has been described, namely that transcription can be
detected at active enhancers [48,49]. The observation added
another layer to enhancer features and it turned out that this might
be the most reliable indicator that the enhancer actively partici-
pates in gene regulation [50]. We will elaborate on this later.
6. Linking enhancers to regulated genes
As far as the genomic features of enhancers are recognized, their
identiﬁcation has been more efﬁcient using enhancer prediction
methods based on both evolutionary conservation [51] and ChIP-
Seq results [52]. Based on factor occupancy and histone marks,
the enhancers can be identiﬁed, but their targeted genes are harder
to ﬁnd. In the absence of a better method, most studies in the ﬁeld
used simply proximity based, predictive approaches to assign
enhancers to the regulated genes [53,54]. Over the past 12 years
the development of 3C methodology and its combination with
NGS technology rapidly changed our view about genome structure
[55]. Traditionally, nuclear organization was evaluated by micros-
copy based methods. Since then, different 3C related methods have
been evolved leading to the 3D determination of chromatin struc-
ture at various gene loci [55]. The advantage of these 3C methods is
their higher resolution compared to microscopy and allowing for
analyzing a single gene and its interaction proﬁle. Importantly,
3C-based approaches will always need a helping hand from theside of microscopy to fully uncover the shape of the genome and
to obtain the most reliable interactions [55] (see also later).
The simplest example is the comparison of gene expression in
active and inactive chromatin regions. Chromatin segregation into
active and inactive regions raised the question whether positioning
into these regions affects gene expression. This was clearly docu-
mented using ﬂuorescent in situ hybridization (FISH), that certain
regions change their nuclear position upon the activating stimulus
[56]. Probably, some of these changes at the level of gene expres-
sion are attributable to cis-acting elements such as enhancers.
The correlation between nuclear position and gene expression
has been shown in several studies, for a review see [55]. Silent
genes are localized closer to nuclear lamina than their active coun-
terparts and supported the basis of the so-called ‘‘position effect’’,
which describes the behavior and action of cis-regulatory elements
in the context of higher-order chromatin structure [55]. Another
emerging concept is the existence of subnuclear compartments
enriched in transcription, called transcriptional factories [56].
These would be highly relevant for enhancer activity and might
even suggest that enhancers and promoters co-localize in such
subnuclear regions.
7. ENCODEing the functional elements
Humans are estimated to have about 20000 protein-coding
genes, but this covers only 1.5% of the entire genome. The other
98% accounts for intronic and intergenic regions, non-coding RNAs
and short or long interspersed elements [57]. ENCODE is a project
launched in 2003 aimed at identifying all the cis-acting elements in
the human genome via the collaboration of several research groups
as part of this specialized consortium [58]. This initiative is the
continuation of the Human Genome Project, but in this particular
case the ﬁnal aim was the identiﬁcation of functional DNA
sequences that act at the protein and RNA levels in a given cell type
[59]. The functional DNA sequences deﬁned as distinct genomic
sections encoding a speciﬁed output for instance, protein product
or non-coding RNA. Another characteristic feature of these ele-
ments is the reproducible biochemical trademark exempliﬁed as
protein binding or speciﬁc chromatin structure. Using 1640 data
sets from 147 different cell types complemented with all ENCODE
data regarding candidate regions from genome-wide association
studies (GWAS) and evolutionarily constrained territories revealed
important components about the function and organization of the
human genome. The main conclusions drawn by the ENCODE con-
sortium were the following: ‘‘(1) More than 80% of the human gen-
ome is associated with at least one biochemical signature in one
particular cell type. (2) Classiﬁcation of the genome into function-
ally different chromatin states implies an initial set of approxi-
mately 400000 enhancer-like regions and more than 70000
promoter-like elements. (3) Quantitative correlation of RNA pro-
duction versus chromatin marks and transcription factor binding
on the promoter regions indicate that RNA expression is mostly
dependent on the functionality of the promoter. (4) ENCODE anno-
tated at least as much functional non-coding DNA sequences as the
protein-coding genes. (5) Single nucleotide polymorphisms (SNPs)
associated with disease phenotypes determined by GWAS enriched
in non-coding functional elements annotated by the consortium’’
[60]. Based on these considerations, it is obvious that the non-cod-
ing part of the genome is full of functional and disease associated
regulatory elements. The basis to connect these to the distal target
genes remained unexplored. Gene promoters and their cis-acting
elements can participate in looping that is involved in gene regula-
tion [17]. In order to link genes and their putative regulatory
regions, chromosome conformation capture carbon copy (5C) is
carried out [13]. 5C interaction maps are generated from three cell
lines and these results were integrated with the ENCODE data.
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between enhancers, CCCTC-binding factor (CTCF) bound sites and
promoters in each cell lines. Signiﬁcant correlations are observed
between gene expression and the existence of promoter-enhancer
interaction and the presence of transcripts originating from
enhancers (enhancer RNAs, eRNAs). Interestingly, unlike the
reported functions of CTCF as an insulator, long-range interactions
are not blocked by CTCF/cohesin co-bound sites, demonstrating
that many of these sites are not demarcated physically insulated
gene domains. The fact that only 7% of the loops are detected with
the closest gene suggests that genomic proximity is not necessarily
a good predictor for long-range interactions [61]. This study clearly
demonstrates that cis-acting elements communicate with their
targeted promoters via looping; nevertheless, if one would like to
reveal the entire interaction map between these elements, one
needs a more robust method capable of detecting all co-operations.
Although 5C is a very powerful method to map the interactions, it
is limited to a single locus. The usage of ChIA-PET solved this issue.
In order to link the regulatory elements to their targets, DNase I
hypersensitive sites (DHS) are resolved leading to the determina-
tion of open chromatin landscape of several cell lines representing
the human genome. These regions were then aligned with RNAPII
ChIA-PET results gathering all the participants of RNAPII depen-
dent open chromatin interactions. This large-scale interaction
analysis conﬁrmed that cooperation between DHS sites and pro-
moters are markedly enriched. Surprisingly, this kind of integra-
tion revealed that approximately half of the DHS sites are
detectable in the close proximity of more than one promoter. These
results suggest that the human cis-acting element network is more
complex than anticipated [62].
Taken together, ENCODE identiﬁed an enormous amount of
functional elements in the human genome and provides a beneﬁ-
cial resource for the ﬁeld. On the other hand, the data presented
has greatly enlarged our understanding about the functionality of
the human genome directing us toward new challenges regarding
cis-acting element annotation and how these act genome-wide.
The functional signiﬁcance of such detected interactions is not
known at all.
8. Pioneering, bookmarking and higher order chromatin
structure
In the previous sections we summarized the knowledge regard-
ing the features of cis-acting elements and how one can recognize
them in the very complex mammalian genome. Each of the genes
encoded in the human or mammalian genetic material is likely
to have many distinct cis-acting elements spread across tens to
hundreds of kilobases. These regulatory sequences act in concert
to ﬁne-tune gene expression in a highly tissue and signal speciﬁc
manner. What kind of factors dictate the functionality of such ele-
ments in the genome leading to differential gene expression pat-
terns in various cell types? Next, we focus on the pioneering and
bookmarking factor concept and on the mechanistic determinants
of higher order chromatin structure contributing to cell speciﬁc
transcription. From a functional point of view there are at least
three categories of enhancers: (1) Potential enhancers not binding
its cognate transcription factor. (2) Non-active enhancers, binding
a particular transcription factor, but not participating in enhance-
ment of transcription and (3) Active enhancers, binding the
required transcription factor and activating transcription. Molecu-
larly, the diversity is likely to be greater. These need to be sorted
out, linked to regulated gene(s) and functionally validated.
From a mechanistic point of view enhancer elements must be
prepared before activation. It has been shown that the forkhead
transcription factor A (FoxA) binds to inactive genomic regions
and by remodeling the nucleosome pattern, it is able to recruitother transcription factors leading to enhancer activation. The ﬁrst
two pioneer factors (FoxA, GATA) have been described in the liver
differentiation program. By deﬁnition, pioneer factors hold the
property to bind nucleosomal DNA and compact chromatin, and
remain bound during mitosis. FoxA is a typical pioneer factor,
which is capable of transforming the actual enhancer to a state
called ‘‘poised’’ for activation [63]. This state of the enhancers ren-
ders them for rapid activation once the speciﬁc signal or its down-
stream effector appears. Other transcription factors have been also
described with pioneer properties, as reviewed in [64]. The preva-
lent view is that during differentiation pioneering factors shape the
active cis-regulatory element network, thus contribute to the
acquisition of cell identity. More precisely, this concept describes
that the regulatory landscape evolved through the differentiation
program determines the sites where transcriptional regulation
occurs. Interestingly, in 2013 Ostuni et al. reported the existence
of the so-called latent enhancers. These cis-elements are not bound
by the lineage-speciﬁc transcription factor PU.1 in terminally dif-
ferentiated macrophages and do not show the characteristic his-
tone proﬁles of enhancers. Importantly, upon stimulation by an
activating signal (IL4, INFg, TGFb), their histone proﬁle can sud-
denly change due to the binding of the downstream effectors and
leads to the subsequent binding of PU.1. After stimulation and in
the absence of the activating signal, most of them do not return
to the latent state. Instead they remain marked by H3K4me1 and
upon exposure, they mediate a faster and stronger response, thus
provides an epigenetic memory to the cell [65]. It remains to be
seen how wide spread is this mechanism among different cell
types.
Taken together, the picture seems quite complex. Cell type spe-
ciﬁc pioneer factors exist and at least in part shape the cis-acting
element landscape across cell types. Other factors affecting the
architecture of the genome have been also shown to be important
in establishing the functional regulatory elements as reviewed in
[66]. At the same time it is also known that not all lineage speciﬁc
transcription factors have chromatin remodeling activities associ-
ated with. Therefore, these are more appropriately called book-
marking factors. It remains to be discovered how these factors
i.e. PU.1 establish cellular memory mechanistically.
It has been shown that each chromosome has its own physical
location in the nucleus, as reviewed [55]. Chromosomal territories
are functionally different and spatially separated, but what are the
determinants of this higher-order chromatin structure, which is
implicated in the regulation of gene expression and also responsi-
ble for cell autonomous transcriptomes?
This line of investigations started when insulator sequences
were ﬁrst recognized in vertebrates [67]. Insulators were described
because of their ability to block enhancer function. Later on, it was
shown that CTCF allows these insulator sequences to function as
separating enhancer/promoter interactions and also active/passive
gene domains [68]. CTCF is a transcription factor possessing elven
zinc-ﬁngers and is ubiquitously expressed in higher eukaryotes.
The function of CTCF was further clariﬁed, showing that it func-
tions with the multiprotein cohesin complex containing the fol-
lowing subunits: SMC1, SMC3, RAD21, SA1, SA2 [69]. Cohesin has
a ring-like shape with a diameter of approximately 60 nm. This
important feature of cohesin makes it suitable to handle the chro-
matin ﬁber as shown in sister chromatid cohesion [70]. According
to the described features of these proteins, it is conceivable that
they are crucial components of shaping the higher-order chroma-
tin structure.
CTCF had long been thought to contribute to the structural
organization of the genome, but its long-range interaction mediat-
ing effect has remained elusive until it has been linked to cohesin
on the mouse Infg locus [71]. This study was the very ﬁrst to show
that both CTCF and cohesin are indispensable for genomic
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diminished promoter–enhancer interactions in embryonic stem
cells [72] and in thymocytes [73]. A series of genome-wide studies
show that CTCF and cohesin co-occupy regions in the genome
[74,75]. The extensive interaction between these factors may
explain how CTCF separates functionally different domains.
Recently, contact mapping of chromosomes determined by
NGS based methods revealed the topological domain structure of
the genome [13,16]. These domains contain multiple genes and
possess differential gene expression activity and epigenetic pat-
tern. Presumably, these domains serve as fundamental building
blocks that support active and passive chromosomal architectures.
It has been shown that the anchoring points of chromatin loops,
organizing the domain structure, are enriched for CTCF and cohe-
sin binding sites [76]. Other studies have reported that CTCF/cohe-
sin co-bound regions mediate the looping events surrounding
promoter enhancer elements, while those regions occupied only
by cohesin are responsible for enhancer–promoter interactions
[72]. Based on these results, several studies showed that CTCF
and cohesin are required to maintain topological domain struc-
tures, interchromosomal interactions and enhancer–promoter
interactions [77–79] (Figs. 1C and 2B). Perturbation of the cohesin
complex has been shown to affect gene expression involving not
only the cohesin bound genes, but also those that are free of cohe-
sin suggesting its function in preserving topological domain struc-
ture [78]. According to these results CTCF and cohesin is likely to
play key roles in proper gene regulation, although their genomic
binding sites suggest that their effects on gene expression are
not cell type speciﬁc because the CTCF cistrome is largely invari-
ant between cell types. As part of the ENCODE project, a study
compared CTCF binding sites from 19 different human primary
and immortal cell lines. Surprisingly, the result shows that there
is plasticity in CTCF binding across cell types indicative of strong
cell-selective regulation of CTCF binding. Using massively parallel
bisulﬁte sequencing, the authors showed that approximately 40%
of variable CTCF binding is due to differential methylation states
at two speciﬁc points of the binding motif. Strikingly, they could
demonstrate that CTCF binding is dramatically different between
primary and immortal cell lines. The latter harbors widespread
disruption of CTCF sites associated with increased methylation
[77].
Taken together, CTCF/cohesin co-bound sites appear to be
responsible, at least in part, for the conﬁguration of topological
domain structure. By shaping the genome architecture these fac-
tors signiﬁcantly contribute to the regulation of gene expression
also in a cell type speciﬁc manner.
9. Is there a function for enhancer RNAs?
Recent advances in genomic technologies made the surprising
ﬁnding that active enhancers are transcribed into RNA molecules,
called enhancer RNAs (eRNA). The ﬁrst results describing the exis-
tence of eRNAs originated from the locus control region (LCR) of
the beta-globin gene clusters [80,81]. The fact that there is perva-
sive transcription on enhancer elements came with the advent of
total RNA sequencing, showing that in neuronal activity regulated
and T-cell speciﬁc enhancers are transcribed [48,49]. More studies
were published recently in the ﬁeld using GRO-Seq in various
cells and species, which have clearly demonstrated that enhanc-
ers are transcribed to eRNAs and to a given stimuli, the activation
dynamics of these elements are similar to their targeted genes
[50,82].
There is a debate on the ﬁeld about eRNA function. The question
is very simple: Are these functionally relevant in gene expression
regulation or eRNAs are just merely byproducts of genetranscription? Recently, several studies published using novel
methods to test the functionality of enhancer-derived transcripts.
Speciﬁc degradation of eRNAs using either RNA interference or
antisense oligonucleotides demonstrated that the expression of
the adjacent gene targeted by the enhancer is reduced [83–86].
Two out of the four studies also performed an eRNA tethering assay
in a reporter system. Interestingly, eRNA connected to either the
promoter [85] or the enhancer [83] was capable of increasing the
expression of the reporter gene. As further evidence, Lam et al.
showed that by integrating various sizes of genomic regions from
an enhancer to a reporter vector could differentially affect the
activity of the reporter gene. If the core sequence was cloned con-
taining the TFBS only, they detected increased reporter activity
compared to a reporter plasmid carrying random DNA sequence.
Surprisingly, the reporter encompassing the core and the entire
eRNA-coding sequence had the highest transcriptional output.
Inverting the eRNA-coding region supported the most striking
result because changing the sequence of the eRNA diminished its
boosting effect, suggesting that the sequence of these short RNAs
can be very important in the context of gene regulation [84].
According to these results, it seems that eRNAs possess regulatory
function, but the question is how. What is the molecular mecha-
nism through which these small molecules reach the heart of
transcription?
It has been demonstrated that enhancers actively participating
in looping with their targeted promoters acquire higher level of
eRNAs [61,87]. Based on these studies, the predicted model must
be that eRNAs somehow secure the contact between enhancers
and their corresponding promoters. Nuclear receptors like estro-
gen receptor alpha (ERa) have been shown to bind enhancer ele-
ments and in the presence of the agonist in this particular case
oestrogen, these cis-acting elements are anchored at target gene
promoters through long-range chromatin interactions determined
by ChIA-PET [17]. Recently, a very important ﬁnding came to light
showing that knockdown of eRNAs immediately next to ERa
bound enhancers reduced enhancer–promoter interactions and
resulted in a reduced expression level of the corresponding gene.
Potentially, these ERa-mediated eRNAs are taking part in the
modulation of looping, which was further supported by the fact
that eRNAs could pull-down the subunits of the cohesin complex.
On the other hand, RNA immunoprecipitation (RIP) assays per-
formed against RAD21 showing that eRNAs could enrich in the
cohesin complex [83], which has been shown to control enhan-
cer–promoter interactions [72]. Furthermore, targeted degrada-
tion of eRNAs by RNA interference led to the inhibition of
oestrogen dependent RAD21 recruitment at several ERa bound
enhancers. Strikingly, knockdown of RAD21 almost fully dimin-
ished the interaction on the gene loci NRIP1 and GREB1 between
the enhancers and their corresponding promoters. In addition,
knockdown of SMC1, another component of the cohesin complex,
almost completely abolished the oestrogen mediated gene activa-
tion program [83]. Thus, eRNAs may participate in the process of
looping by initiating or stabilizing the interactions of enhancer–
promoter pairs.
In an independent study by Hah et al. showed that inhibiting
RNAPII elongation (by ﬂavopiridol) has no signiﬁcant effect on
the looping examined on the P2RY2 and GREB1 loci using 3C
[88]. These results put a little bit of contradiction into the ﬁeld,
but the difference may be explained by the usage of different
experimental systems (eRNA silencing vs. Pharmacological inhibi-
tion of RNAPII elongation) or these may reﬂect different mecha-
nisms at different gene loci [43].
Overall these studies suggest that at least in some cases eRNAs
possess regulatory function and contributes to gene expression
regulation. Clearly, further studies are needed to clarify their roles.
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Previously we summarized the main features of an enhancer
element and also delineated their annotation to their correspond-
ing genes, than we dealt with eRNA function. In this part we sum
up those studies, which connect single nucleotide polymorphisms
(SNPs) with cis-acting elements supporting the notion that SNPs in
the regulatory regions may cause disease phenotypes and thus
contributes to evolution. Disruptions in chromosomal regions not
harboring coding genes provided the ﬁrst evidence that mutations
in the non-coding part of the genome may contribute to disease
development. 1.8% of the identiﬁed point mutations fell in the
non-coding part of the genome based on the Human Gene Muta-
tion Database.
Mutations in the cis-acting elements can be easily annotated to
a given disease phenotype if they fulﬁll one or more of the follow-
ing: (1) Genetic evidence is present to link the phenotype to a
known disease locus. (2) Validated chromosomal anomaly (dele-
tion, ampliﬁcation, rearrangement) can be annotated to a known
disease gene. (3) Resulting phenotype is very similar to the pheno-
typic change caused by a mutation in the coding region of a known
disease gene. (4) Disease associated variation accounts for all or a
signiﬁcant fraction of disease risk [89].
One of the earliest studies mentioned the regulatory element
mutations of the PAX6 locus involved in Aniridia. Aniridia is char-
acterized by the absence of iris and is mostly due to mutations
occurred in the coding sequence of the PAX6 gene [90]. However,
a fraction of the cases are not caused by mutations in the coding
sequence. It has been shown that the downstream genomic region
is full of rearrangements. The most distal point harboring the
mutation lies approximately 125 kb from the last exon of PAX6
and fall in the intronic region of the ubiquitously expressed gene
ELP4, although haploinsufﬁciency for ELP4 has been shown not
to contribute to the disease phenotype. YAC-based transgene
experiments in mice revealed an approximately 80 kb long geno-
mic region containing series of DHSs. Later on, it has been
described that these cis-acting elements are required for PAX6
expression [91].
Another striking example has been demonstrated with the
POU3F4 gene. Mutations occurred in the coding region responsible
for X-linked deafness type 3, however a smaller group of cases was
identiﬁed that lack the gene variation. Interestingly, approximately
900 kb upstream from the gene’s TSS, a very important 2 kb ele-
ment has been described to overlap with an otic vesicle enhancer,
likely regulating POU3F4 [92].
These experiments have shown that regulatory elements func-
tion over long distances, they can reside in other transcriptional
units and their mutations can cause disease phenotypes. The listed
diseases are typically inherited in a Mendelian manner, although
mutations present in the non-coding regions of the genome where
they associated with non-Mendelian diseases.
The rapid evolution of genotyping technologies has resulted in
GWAS data that generally imply a powerful role for regulatory var-
iation in common genetic disorders [93]. Recently, meta-analysis
of approximately 1200 SNPs representing the most signiﬁcant
association with disease phenotypes has been done. Surprisingly
40% of these fall into the non-coding part of the genome, suggest-
ing that disease causing mutations may act on enhancer elements
[94].
Several studies successfully demonstrated roles for non-coding
mutations in disease risk. One of the earliest was identiﬁed in the
intronic region of the RET gene contributing to Hirschprung disease
[95]. Recently, it has been shown that a mutation residing in the
non-coding region belonging to the IRF6 gene is a risk factor of cleft
lip associated with Van der Woude Syndrome [96]. Similar obser-
vations have been made in several other cases, as reviewed in [89].Overall, the vast amount of data unequivocally support the
notion that cis-acting elements are crucial components of proper
gene regulation and their mutations give rise to various patholog-
ical conditions. Importantly, until now no one could investigate the
effect of these genetic variations on the functional cis-acting ele-
ment toolkit in a special cell type.
Recently, Heinz et al. used different mouse strains looking for
differential binding of transcription factors caused by natural
genetic variation. In this study they could delineate the strain spe-
ciﬁc differences in functional enhancer usage in macrophages.
Most of the cells express hundreds of transcription factors to con-
trol the non-coding part of the genome, thus shaping the cell spe-
ciﬁc transcriptome. In macrophages, transcription factors
responsible for marking regulatory elements are PU.1, C/EBPs and
the AP-1 family members. They showed that in macrophages these
lineage determining transcription factors (LDTF) collaboratively
occupy 70% of the active enhancer elements. Surprisingly, if a
SNP can be detected in the PU.1 motif leading to diminished PU.1
binding, it is negatively affected by the binding of the other two
LDTFs. Conversely, if the binding motif of C/EBP or AP-1 harbors
the mutation, PU.1/AP-1 and PU.1/C/EBP binding also diminished.
In addition, H3K4me2 and H3K27ac markers of active enhancers
are also abolished, meaning that these enhancers were no longer
functional. These results provided a deﬁnitive answer to the ques-
tion: How enhancer function and transcription factor binding is
lost where there are no mutations in its binding motif? Based on
these, the answer is the requirement for collaborative binding.
Interestingly, further examination of the strains in the context of
a signal speciﬁc transcription factor, NF-jB, led to the observation
that mutations occurred in the LDTF motifs are approximately
three times more likely to result in decreased NF-jB binding, than
mutations occurred in the NF-jB motif. This observation showed
the importance of LDTFs in chromatin priming/remodeling, as pre-
viously mentioned [97].
The authors claim that this collaborative binding model can be
very useful if one determines the LDTFs in a given cell type and
merge these binding sites with the annotated genetic variations
to pinpoint the potential disease-causing variants. The future chal-
lenges will be to expand these studies and use them in different
model systems to understand disease-causing natural genetic vari-
ations [97].
11. Conclusions and future directions
Transcriptional control of cell speciﬁc gene expression is carried
out through complex molecular mechanisms. Recent works har-
nessing the advantage of the integration of high-throughput
sequencing data led to the identiﬁcation of active enhancer ele-
ments in various cell types. Enhancers seem to be highly tissue
speciﬁc, explained by the presence of different pioneering factors
establishing the cis-acting element repertoire and the higher order
chromatin structure, shaped partly by CTCF and CTCF/cohesin, to
our best knowledge. Genomic regions are partitioned into func-
tionally distinct gene domains, in which regulatory elements may
act on various genes. Signal speciﬁc gene expression regulation
often carried out over long distances covered by chromatin loops
between the regulator and the regulated gene. Functional enhanc-
ers actively engaged in looping and possess the ability to be tran-
scribed to eRNAs. These short RNA pieces originated from
enhancers seem to be important components of those protein com-
plexes taking part in looping. Importantly, this process, at least in
general terms, is indispensable for efﬁcient assembly of transcrip-
tion initiation machinery on target gene promoters. Although these
studies greatly improved our understanding about gene regulation,
still inherently descriptive harboring the disadvantage that we
could not render a clear biological function to these cis-elements
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knowing the enhancer SNP location. In the future, probably most
of the enhancers will be eliminated by using genome-editing
methods, for instance TALEN [98] or CRISPR [99] in order to test
their functions. Genome editing is expected to fulﬁll the expecta-
tion that the molecular function of each element will be identiﬁed
and by these means create the opportunity to selectively target
each of them to cure diseases. The results obtained from the silenc-
ing of eRNAs are also promising, showing that targeting an enhan-
cer transcript derived from an active cis-acting element may has an
effect on the target gene expression, thus serves as a remote con-
trol for genes. The problems with these are: (1) Their speciﬁcity
is questionable because one enhancer can be responsible for the
regulation of several genes. (2) Presence of shadow enhancers
[100] can compensate the effect of the original enhancer. (3) Hit-
ting the target speciﬁcally under a physiological setting.
All together integration based genomics holds the potential to
reveal many new drug targets and to identify most of the disease
causing mutations, which may be located in the non-coding part
of the genome and so far was very cumbersome to seek out.
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